Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Shitiz Sriwastava to Antineoplastic Agents

This is a "connection" page, showing publications Shitiz Sriwastava has written about Antineoplastic Agents.

 
Connection Strength
  
 
 
0.537
  
  1. Tolaymat S, Sharma K, Kagzi Y, Sriwastava S. Anti-CD20 monoclonal antibody (mAb) therapy and colitis: A case series and review. Mult Scler Relat Disord. 2023 Jul; 75:104763.
    View in: PubMed
    Score: 0.456
  2. Desai A, Sriwastava S, Gadgeel SM, Lisak RP. New onset myasthenia gravis in a patient with non small cell lung cancer treated with lorlatinib a novel anti-cancer agent. J Neurol Sci. 2018 09 15; 392:100-101.
    View in: PubMed
    Score: 0.081
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.